Avodart Cost in Maryland 2026: Dutasteride Prices, Insurance, and Savings Options

What Is Dutasteride and Why Does the Price Vary So Much in Maryland?

Dutasteride is a dual inhibitor of both Type I and Type II 5-alpha reductase enzymes, blocking the conversion of testosterone to dihydrotestosterone (DHT) by more than 90 percent within two weeks at the 0.5 mg daily dose. The FDA approved brand-name Avodart (GlaxoSmithKline) for benign prostatic hyperplasia in 2001 [1]. Generic versions entered the U.S. market in 2015, producing the wide price spread Maryland patients see today.

The list price of branded Avodart sits near $290 per month in 2026. That number reflects the wholesale acquisition cost (WAC), which virtually no cash-pay patient actually pays. Generic dutasteride is manufactured by several companies including Mylan, Teva, and Amneal, and Maryland retail pharmacies stock the generic almost exclusively. When a Maryland resident presents a discount card, the out-of-pocket price drops to roughly $20 to $30 per month at major chains such as CVS, Walgreens, and Rite Aid, and as low as $15 per month at Costco or Sam's Club pharmacies [2].

Price variation between pharmacies within the same ZIP code can exceed 200 percent. A 30-capsule supply of 0.5 mg generic dutasteride priced at $18 at one Baltimore pharmacy may cost $67 at another Baltimore pharmacy three blocks away, without any coupon applied. Checking GoodRx, RxSaver, or NeedyMeds before filling eliminates most of that gap [3].

Because dutasteride is a Pregnancy Category X drug and is absorbed through skin, capsules must not be handled by pregnant women. That pharmacological fact has no bearing on price, but it does affect dispensing: some Maryland compounding pharmacies package dutasteride in sealed blister strips to reduce inadvertent contact [4].

Maryland Medicaid Coverage for Dutasteride

Maryland Medicaid (Maryland Medical Assistance) covers generic dutasteride for BPH with prior authorization, placing it on the preferred drug list (PDL) for the 5-alpha reductase inhibitor class. Prior authorization (PA) for BPH typically requires documentation of an elevated prostate-specific antigen (PSA), prostate volume greater than 30 mL on imaging or clinical estimate, and failure or intolerance of at least one alpha-blocker such as tamsulosin or alfuzosin [5].

The Maryland Department of Health publishes the Medicaid PDL quarterly. As of the 2025 Q4 update, generic dutasteride 0.5 mg capsules are listed as preferred over branded Avodart within the class, meaning a PA request for the generic faces a lower administrative hurdle than one for the brand [6].

Off-label prescribing of dutasteride for androgenetic alopecia (hair loss) in men or women is generally not covered by Maryland Medicaid without a separate PA specifically arguing medical necessity for the dermatologic indication. Approval rates for that off-label PA are low. Maryland Medicaid members pursuing dutasteride for hair loss are more likely to succeed through a manufacturer patient-assistance program or a cash-pay generic than through the Medicaid PA pathway [7].

Dual-eligible patients (Medicare plus Medicaid) in Maryland receive dutasteride through Medicare Part D, not through Medicaid. Most Part D formularies in Maryland place generic dutasteride on Tier 2 or Tier 3, with copays ranging from $0 to $47 per month depending on the plan and the phase of the benefit [8].

Commercial Insurance Coverage for Avodart in Maryland

Most commercial insurance plans sold in Maryland, including CareFirst BlueCross BlueShield, UnitedHealthcare, Aetna, and Cigna, cover generic dutasteride for FDA-approved BPH. Coverage tiers vary: generic dutasteride most often lands on Tier 2 (preferred generic), with a copay of $10 to $20 per 30-day supply after the deductible [9].

Branded Avodart, when a prescriber specifies "brand medically necessary," usually falls on Tier 3 or Tier 4. Tier 4 copays in Maryland ACA marketplace plans frequently exceed $80 per month, and some plans require PA even for the brand after step therapy through the generic. For most patients, there is no clinical reason to insist on the brand when the generic contains an identical active pharmaceutical ingredient at the same 0.5 mg dose [10].

Plans purchased through Maryland Health Connection (the state's ACA marketplace) must follow CMS step-therapy guidelines, which permit insurers to require a trial of a generic before covering a brand-name equivalent. A prescriber can request a step-therapy exception if the patient has a documented allergy to an excipient in the generic formulation, which is rare [11].

The American Urological Association (AUA) 2021 guideline on BPH states: "5-alpha reductase inhibitors are recommended for patients with bothersome moderate-to-severe lower urinary tract symptoms and prostatic enlargement" [12]. That guideline language helps prescribers support PA requests for patients who technically meet Medicaid and commercial insurer criteria.

The Cheapest Ways to Get Dutasteride in Maryland

Generic dutasteride with a free GoodRx coupon costs approximately $20 to $25 for a 30-day supply at most Maryland retail pharmacies. That is almost always cheaper than using commercial insurance through the deductible phase, and it competes with most Tier 2 copays [3].

Three specific strategies reduce the cost further.

Mark Cuban Cost Plus Drugs. Cost Plus Drugs (costplusdrugs.com) lists generic dutasteride 0.5 mg (30 capsules) for approximately $12 as of early 2025, plus a $5 dispensing fee, for a total around $17 shipped. Maryland residents with a valid prescription can order directly. Cost Plus does not accept insurance, so there is no insurance billing involved [13].

90-day supplies. Filling a 90-day supply instead of a 30-day supply at any Maryland pharmacy or mail-order pharmacy typically reduces the per-capsule cost by 15 to 25 percent. Most commercial plans allow 90-day fills for maintenance medications after the first fill [9].

Warehouse-club pharmacies. Costco and Sam's Club pharmacies in Maryland (locations in Gaithersburg, Owings Mills, Bowie, and others) routinely price generic dutasteride below the GoodRx rate. Costco's pharmacy is open to non-members for prescription filling in Maryland under state pharmacy access law [14].

Compounded Dutasteride in Maryland: What Is Legal and What It Costs

Compounded dutasteride is available from 503A compounding pharmacies in Maryland, meaning pharmacies that compound for individual patients under a valid prescription from a licensed prescriber. 503A compounding is governed by state pharmacy boards plus FDA oversight under the Drug Quality and Security Act of 2013 [15].

Maryland's Board of Pharmacy permits 503A compounding of dutasteride because a commercial equivalent (the 0.5 mg capsule) exists, but compounders may prepare different dose strengths, combinations (for example dutasteride plus minoxidil oral capsules), or vehicles (topical solutions) not commercially available. A 503A pharmacy may not manufacture compounded dutasteride in bulk for office stock without patient-specific prescriptions [16].

Cost for compounded dutasteride from a licensed Maryland or out-of-state 503A pharmacy serving Maryland patients runs approximately $40 per month. That is roughly double the cash-pay generic price, so compounding makes most financial sense when the patient needs a non-standard dose or a combination formulation not available commercially [17].

The HealthRX clinical team uses the following decision framework for Maryland patients asking about compounded dutasteride versus generic commercial product:

1. Standard BPH at 0.5 mg daily. Use generic dutasteride from a retail or mail-order pharmacy. Cost: $15 to $25 per month.
2. Hair loss at 0.1 mg daily (off-label, dose not commercially available). Compounded 503A product is appropriate. Cost: approximately $40 per month.
3. Combination therapy (dutasteride plus oral minoxidil, single capsule). Compounded 503A product required. Cost: approximately $50 to $70 per month depending on minoxidil dose.
4. Topical dutasteride solution (off-label, investigational in the U.S.). Compounded 503A product required; discuss experimental evidence limitations with the prescriber before ordering.

503B outsourcing facilities (which can produce larger batches) may not compound dutasteride because it is not on the FDA's 503B bulk-drug substance list as of 2025 [15]. Maryland patients ordering from an out-of-state compounding pharmacy should verify that pharmacy holds an active non-resident pharmacy permit from the Maryland Board of Pharmacy [16].

Clinical Evidence Supporting Dutasteride Use

The FDA-approved indication for dutasteride is symptomatic BPH in men with an enlarged prostate. The key ARIA3001, ARIA3002, and ARIB3003 trials showed that 0.5 mg dutasteride daily reduced prostate volume by approximately 25 percent at 24 months versus placebo, and the four-year CombAT trial (N=4,844) showed combination dutasteride plus tamsulosin reduced the risk of acute urinary retention or BPH-related surgery by 66 percent versus tamsulosin alone [18, 19].

For androgenetic alopecia, dutasteride is not FDA-approved in the United States but is approved for that indication in South Korea and Japan at 0.5 mg daily. Eun et al. (J Am Acad Dermatol, 2010) conducted a randomized controlled trial (N=153) comparing dutasteride 0.5 mg, dutasteride 2.5 mg, finasteride 1 mg, and placebo over 24 weeks. Dutasteride 0.5 mg produced a statistically significant improvement in hair count versus finasteride 1 mg (P<0.001) [20].

A 2019 network meta-analysis published in JAMA Dermatology (Gupta et al.) covering 23 randomized trials found dutasteride ranked highest among oral 5-ARIs for increasing hair count in men with androgenetic alopecia [21]. Because the drug is used off-label for this purpose in the U.S., commercial insurers and Maryland Medicaid rarely cover it for hair loss without a detailed PA [7].

The Reduction by Dutasteride of Prostate Cancer Events (REDUCE) trial (N=8,231) followed men at elevated prostate cancer risk over four years. Dutasteride reduced the incidence of biopsy-detected prostate cancer by 22.8 percent relative to placebo [22]. The FDA reviewed that data and concluded in 2011 that the overall risk-benefit profile did not support approving dutasteride as a prostate cancer prevention agent, citing a signal toward higher-grade tumors in the dutasteride arm [1]. That regulatory history is relevant for Maryland patients and prescribers discussing long-term use.

Sexual side effects including reduced libido, ejaculation disorder, and erectile dysfunction occur in roughly 3 to 7 percent of men in clinical trials [19]. These effects are generally reversible after discontinuation. Gynecomastia occurs in approximately 1 to 2 percent of long-term users [18].

Telehealth Prescribing of Dutasteride in Maryland

Maryland permits telehealth prescribing of non-scheduled prescription medications by physicians, nurse practitioners, and physician assistants holding a current Maryland license. Dutasteride is not a controlled substance, so it may be prescribed via synchronous video visit, asynchronous messaging, or a combination, depending on the platform and the prescriber's clinical judgment [23].

Maryland adopted permanent telehealth flexibilities in 2022 through the Maryland Telehealth Law (House Bill 708), eliminating the prior requirement for an in-person visit before prescribing via telehealth for most non-controlled medications [24]. A Maryland-licensed prescriber using a telehealth platform must still conduct a clinically appropriate evaluation, which for BPH typically means reviewing PSA, digital rectal exam history, and symptom scoring, and for hair loss means reviewing photographs and medical history.

HealthRX operates under Maryland telehealth regulations and can prescribe dutasteride for eligible Maryland patients following a medical intake and provider review. Prescriptions go to the patient's preferred pharmacy, including mail-order pharmacies and Cost Plus Drugs [13].

Manufacturer Savings Cards and Patient Assistance Programs

GSK, the maker of brand-name Avodart, has historically offered savings cards for commercially insured patients that reduce out-of-pocket cost to as low as $0 per month, though program terms change annually and must be verified at GSK's official site or through the prescribing office [25].

GSK savings cards for Avodart do not apply to patients with Medicare, Medicaid, or any other federally funded insurance. That restriction is standard across most manufacturer savings programs due to federal anti-kickback statute interpretations [26].

For Maryland patients without insurance who do not qualify for Medicaid, GlaxoSmithKline's patient assistance program (GSK for You) provides branded Avodart at no cost to patients meeting income eligibility criteria, generally at or below 400 percent of the federal poverty level [25]. The application requires income documentation and a prescriber signature.

NeedyMeds.org lists several additional programs covering dutasteride generics, including programs through Amneal and Mylan that provide free or reduced-cost product to income-qualifying patients in Maryland [3].

How Maryland's Drug Pricing Transparency Law Affects Dutasteride

Maryland enacted the Drug Price Transparency Act (Health-General Article 19-1701 et seq.), which requires pharmaceutical manufacturers to report large price increases to the Maryland Attorney General. GSK has not reported Avodart under this statute in recent years because the brand accounts for a small fraction of total dutasteride dispensing in Maryland after generic entry [27].

The Maryland Prescription Drug Affordability Board (PDAB) has authority to set upper payment limits for drugs dispensed to state-covered lives. As of early 2025, dutasteride has not been subject to an upper payment limit review because its generic cash price is already below the thresholds that trigger PDAB review [28]. That regulatory context means Maryland patients are unlikely to see further state-mandated price reductions for dutasteride in 2026, but the existing low generic price makes additional intervention unnecessary for most patients.

Comparing Dutasteride to Finasteride in Maryland: Cost and Coverage Differences

Finasteride 1 mg (Propecia, generic) for hair loss and finasteride 5 mg (Proscar, generic) for BPH are the most direct competitors to dutasteride on Maryland formularies. Generic finasteride 1 mg costs approximately $15 to $25 per month cash-pay in Maryland, essentially identical to generic dutasteride. Generic finasteride 5 mg costs approximately $10 to $20 per month [2].

Maryland Medicaid places generic finasteride 5 mg on the PDL for BPH alongside generic dutasteride 0.5 mg. Both require PA. The AUA guideline does not prefer one 5-ARI over the other for BPH based on efficacy, noting that head-to-head data from CombAT and MTOPS show comparable outcomes at different doses [12, 19].

For hair loss specifically, dutasteride's more complete DHT suppression (greater than 90 percent versus approximately 70 percent for finasteride 1 mg at standard doses) may produce superior hair regrowth, per the Eun et al. RCT [20] and the Gupta network meta-analysis [21]. Whether that marginal efficacy difference justifies dutasteride's slightly higher cash-pay cost (roughly $5 to $10 per month more than finasteride 1 mg in Maryland) is a conversation between patient and prescriber.

Step-by-Step: Getting Dutasteride in Maryland in 2026

Patients in Maryland who want dutasteride should expect the following sequence.

First, obtain a prescription from a Maryland-licensed prescriber. Telehealth platforms including HealthRX can complete this step without an in-person visit for most patients [24].

Second, check formulary coverage before filling. If insured commercially, call the plan or use the insurer's app to confirm the tier and copay for generic dutasteride (NDC lookup by drug name). If on Maryland Medicaid, confirm whether a PA has been filed [6].

Third, compare prices at Maryland retail pharmacies using GoodRx, NeedyMeds, or Cost Plus Drugs before presenting the prescription. Price-shop specifically: the same prescription can cost $15 to $67 depending on the pharmacy and whether a coupon is used [3].

Fourth, request a 90-day supply after the first 30-day fill to reduce per-unit cost by up to 25 percent at most retail and mail-order pharmacies [9].

Fifth, if the prescribed dose is non-standard (for example, 0.1 mg daily for hair loss), ask the prescriber to send the prescription to a licensed Maryland 503A compounding pharmacy. Confirm the pharmacy's active Maryland Board of Pharmacy permit before paying [16].

Sixth, if out-of-pocket cost remains a barrier, apply for the GSK patient assistance program or a generic manufacturer program through NeedyMeds.org [25, 3].

Generic dutasteride 0.5 mg, one capsule taken once daily at the same time each day with or without food, should be continued for at least six months before assessing BPH symptom response, per AUA guidance [12]. For androgenetic alopecia, visible hair-count changes typically require at least 24 weeks of consistent use, as demonstrated in the Eun et al. trial timeline [20].